{"id":751,"date":"2019-10-02T15:30:10","date_gmt":"2019-10-02T02:30:10","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=751"},"modified":"2019-10-02T15:36:42","modified_gmt":"2019-10-02T02:36:42","slug":"cll-horizons-workshop","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=751","title":{"rendered":"CLL Horizons and workshop \u2013 an update"},"content":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”3″ bottom_padding=”3″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column width=”1\/1″][vc_custom_heading heading_semantic=”h1″ text_size=”h1″]CLL Horizons and workshop \u2013 an update[\/vc_custom_heading][vc_gallery el_id=”gallery-145080″ isotope_mode=”fitRows” medias=”760,759,758″ gutter_size=”2″ media_items=”media|lightbox|poster,icon” screen_lg=”1000″ screen_md=”600″ screen_sm=”480″ single_width=”2″ images_size=”one-one” single_overlay_opacity=”50″ single_padding=”2″][vc_column_text]I\u2019ve just returned from attending two back-to-back conferences on CLL in Edinburgh. The first was the international \u00a0CLL Advocates Network (CLLAN) Horizons<\/em> conference for CLLAN members. The second was the 2019 International Workshop on CLL (iwCLL), a major medical and scientific meeting. Both conferences were excellent.<\/p>\n

Horizons<\/em> focused on CLL patient advocacy group models from around the world, what made them work, where improvements could be made, and where the future was heading. There was a lot of discussion on sharing of resources amongst the various groups, so as not to \u201creinvent the wheel\u201d, and you will soon see examples of this here on our site.<\/p>\n

Psychosocial support provision, use of social media to communicate among individuals and groups, examples of successful advocacy, and the various ways in which advocacy groups can make positive contributions to research were major components of the formal presentations. There were also several presentations about the current state of the science and medical therapeutics of the disease CLL.<\/p>\n

I was invited to present the story of a new advocates\u2019 group, on how we\u2019re developing CLLANZ and lessons learned, as well as the future role of the organisation. Click below to view my presentation.<\/p>\n

\"\"<\/a><\/p>\n

The iwCLL meeting (attended by close to 2000 delegates) covered in great detail the science and the medicine of CLL in 2019, and the directions investigative science and medical therapeutics will take in the next few years.<\/p>\n

I will be sharing specific aspects of interest \u00a0from the conference presentations with you on this website , over the next few weeks, linked to areas of research and treatments<\/p>\n

Best wishes<\/p>\n

\"\"<\/p>\n

Neil Graham[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Horizons focused on CLL patient advocacy group models from around the world, what made them work, where improvements could be made, and where the future was heading. <\/p>\n","protected":false},"author":1,"featured_media":759,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12,17],"tags":[],"class_list":["post-751","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","category-featured"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2019\/10\/Group-photo.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=751"}],"version-history":[{"count":8,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/751\/revisions"}],"predecessor-version":[{"id":768,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/751\/revisions\/768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/759"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}